Catalysts for Efudex
42 tracked
Apr 28, 2026
phase 1 initiation
Virginia Commonwealth University — fluorouracil (Phase I Trial Initiation)
Efudex
→
Apr 25, 2026
phase 2 completion
Tianjin Medical University Cancer Institute and Hospital — fluorouracil (Phase II Trial Completion)
Efudex
→
Feb 20, 2026
approval
FAVLYXA (FLUOROURACIL) — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 5, 2026
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Oct 18, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 3, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Sep 14, 2022
approval
FLUOROURACIL — FDA approval
Efudex
→
Sep 14, 2022
approval
FLUOROURACIL — FDA approval
Efudex
→
Dec 26, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Oct 27, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
May 11, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Jan 6, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→
Jan 6, 2017
approval
FLUOROURACIL — FDA approval
Efudex
→